Award
Indiana University Indianapolis 5U01DK065211-24
IU Clinical Center: Drug Induced Liver Injury Network
Recipient
Indiana University Indianapolis
Award Amount
$383,751.00
Ceiling
$383,751.00
Awarded
August 04, 2026
Identifier
5U01DK065211-24
Indiana University received an award to conduct research on drug-induced liver injury, including patient enrollment, ancillary studies, and a clinical trial of saroglitazar, funded by NIH RFA-DK-22-013 with $383,751 for FY 2026.
Description
This project involves research on drug-induced liver injury (DILI) with multiple specific aims including enrollment of patients, ancillary studies on transcriptome and HLA variants, and a clinical trial of saroglitazar. The project is funded by NIH RFA-DK-22-013 with a total award amount of $383,751 for FY 2026.